Connecticut HB 5389: AN ACT CONCERNING A PROVIDER TOOLKIT FOR THE DIAGNOSIS AND TREATMENT OF MENOPAUSE, PERIMENOPAUSE AND POSTMENOPAUSE.

Status: TABLED FOR HOUSE CALENDAR (as of 2026-04-15)

State: Connecticut · Session: 2026 · Bill: HB 5389

Subjects: Government information, Health care providers, Occupational training, Public Health, Department of, Public health, Women

Sponsors: Amy Morrin Bello, Anthony L. Nolan, Antonio Felipe, Eleni Kavros Degraw, Jaime S. Foster, James Sanchez, Josh Elliott, Julie Kushner, Kai J. Belton, Kate Farrar, Kathy Kennedy, Laurie Sweet, Martha Marx, Nick Gauthier, Patricia A. Dillon, Roland J. Lemar, Sarah Keitt, Trenee Mcgee

Bill Text

LCO  
 
1 of 2 
  
General Assembly  
Substitute Bill No. 5389  
February Session, 2026 
 
 
 
 
 
AN ACT CONCERNING A PROVIDER TOOLKIT FOR THE DIAGNOSIS 
AND TREATMENT OF MENOPAUSE, PERIMENOPAUSE AND 
POSTMENOPAUSE.  
Be  it enacted  by  the  Senate  and  House  of  Representatives  in  General 
Assembly convened: 
 
Section  1.  (NEW) (Effective  October  1,  2026)  (a)  The  Department  of 1 
Public  Health,  in  consultation  with  The  University  of  Connecticut 2 
Health   Center's   Health   Disparities   Institute,   persons   who   have 3 
experienced symptoms of perimenopause, menopause and 4 
postmenopause,  and  health  care  providers  who  treat  persons  with 5 
symptoms  of  perimenopause,  menopause  and  postmenopause,  shall 6 
develop a toolkit that provides practical, evidence-based and culturally 7 
appropriate  guidance  to  health  care  providers  in  the  state  who  are 8 
responsible  for  diagnosing  or  treating  persons  with  symptoms  of 9 
menopause,  perimenopause  or  postmenopause,  as  determined  by  the 10 
commissioner, including, but not limited to, health care providers in the 11 
fields  of  obstetrics,  gynecology,  internal  medicine,  family  medicine, 12 
emergency medicine, psychiatry, mental health, social work, dentistry, 13 
dental  hygiene  and  community  health,  regarding  best  practices  for 14 
screening, identification, clinical assessment, diagnosis and treatment of 15 
symptoms  of  menopause,  perimenopause  and  postmenopause.  Such 16 
guidance shall include, but need not be limited to, (1) a comprehensive 17 
description   of   the   symptoms   of   menopause,   perimenopause   and 18 

Substitute Bill No. 5389 
 
 
LCO      2 of 2 
 
postmenopause,     (2)     evidence-based     guidelines     regarding     the 19 
identification  and  treatment  of  such  symptoms,  including,  but  not 20 
limited to, the use of hormones, such as hormone replacement therapy 21 
and testosterone therapy, (3) the availability of insurance coverage for 22 
such   therapies,   and   (4)   short   education   modules   regarding   such 23 
guidance  that  would  qualify  as  continuing  education  for  such  health 24 
care providers. 25 
(b)  Not  later  than  June  1,  2028,  the  Commissioner  of  Public  Health 26 
shall distribute the toolkit developed pursuant to subsection (a) of this 27 
section to such health care providers. Not later than January 1, 2029, the 28 
commissioner shall (1) evaluate any feedback received from such health 29 
care  providers  regarding  the  effectiveness  of  the  toolkit,  (2)  revise  the 30 
toolkit  as  necessary  to  address  such  feedback,  and  (3)  distribute  a 31 
revised toolkit, if any, to such health care providers. 32 
This act shall take effect as follows and shall amend the following 
sections: 
 
Section 1 
October 1, 2026 
New section 
 
PH Joint Favorable Subst.  
APP Joint Favorable

View Connecticut HB 5389 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.